Bayer CH Backs Digital Therapeutics With ‘Multimillion-Dollar’ Mahana Partnership

A multimillion-dollar partnership will bring together Bayer Consumer Health's digestive health brand equity with Mahana's cutting edge digital therapeutic technology for treating irritable bowel syndrome. 

• Source: Shutterstock

Bayer Consumer Health is entering a “multimillion-dollar distribution and marketing partnership” with San Francisco based company Mahana Therapeutics.

With Mahana offering via prescription in the US what it describes as the “only FDA-cleared digital cognitive behavioral therapy treatment...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Digital Technologies

More from HBW Insight